X

Health & Biotech

Lock us up! ASX investors likely winners from Victoria lockdown

Supermarket shelves are bare again, sly Bumble dates are relegated back to the park, and last night houses were lit…

Weed Week: Kiwi polling points to a tight race as cannabis referendum looms

This week's weed news comes from across the Tasman, where New Zealanders are preparing to vote on a referendum to…

Check up: Speeding tickets all round

Here’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 132-odd small cap health stocks…

Althea becomes first local cannabis player to launch online sales channel

Pharmaceutical company Althea Group (ASX:AGH) had some interesting distribution news, announcing the Australian-first launch of an online channel for its…

Victoria’s lockdown helps Global Health win new business, shares rise 60pc+

Global Health (ASX:GLH) continues to win new business in Victoria, with the state again re-entering lockdown proving a catalyst for the…

Fresh off US success, LBT moves on Europe

Fresh off its first sale in the US and positive results from a John Hopkins School of Medicine study, LBT…

Allegra rockets 500pc+ after taking ownership of synthetic bone substitute IP

After six years of collaborating with the University of Sydney on a synthetic bone substitute, Allegra Orthopaedics (ASX:AMT) today acquired…

Greg Hunt revives one-stop-shop idea for Aussie clinical trials

Health Minister Greg Hunt has revived a long-standing plan to turn Australia into a "one stop shop" for clinical trials,…

Nyrada one step closer to cholesterol pill, shares surge

Nyrada (ASX: NYR) has received "encouraging" results from a lab-based cholesterol-lowering study, for the drug it hopes to use to…

The watchlist of likely losers from Victoria re-entering lockdown

Domestic travel companies, financial services, non-discretionary retailers, real estate investment trusts (REITs), and toll road operator Transurban (ASX:TCL) are on…